Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : License symbols : Sny save search
Regeneron Provides Update on Biologics License Application for Odronextamab
Published: 2024-03-25 (Crawled : 11:00) - globenewswire.com
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 0.42%
H: 0.0%
C: 0.0%
REGN | $901.27 0.8% 0.78% 470K
|
Health Technology
|
| O: -1.37%
H: 1.15%
C: 0.74%
license update application
Maze Therapeutics Announces FTC Action Seeking to Block Collaboration and License Agreement with Sanofi Regarding MZE001, a Potential Oral Substrate Reduction Therapy for Pompe Disease
Published: 2023-12-11 (Crawled : 00:00) - biospace.com/
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: 0.5%
H: 1.67%
C: 0.1%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 2.15%
H: 0.0%
C: 0.0%
mze001 disease license collaboration therapeutics potential agreement therapy sanofi
Press Release: Statement on FTC challenge to proposed license agreement with Maze Therapeutics
Published: 2023-12-11 (Crawled : 21:00) - globenewswire.com
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 0.43%
H: 0.0%
C: 0.0%
license therapeutics agreement
Simcere and Connect Enter into an exclusive license and collaboration agreement for the innovative autoimmune drug Rademikibart
Published: 2023-11-23 (Crawled : 08:00) - prnewswire.com
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
| Email alert
Add to watchlist
drug license collaboration agreement
First Wave BioPharma Announces Exclusive Global License Agreement for Capeserod from Sanofi
Published: 2023-09-14 (Crawled : 10:00) - globenewswire.com
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: 2.14%
H: 0.0%
C: -1.3%
FWBI | News | $2.98 -1.33% -1.34% 50K
|
Manufacturing
|
| O: 109.38%
H: 21.84%
C: -44.24%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 0.26%
H: 0.74%
C: 0.33%
license biopharma global agreement sanofi
Idorsia sells its Asia Pacific (ex-China) operations – including select license rights to products – to Sosei Heptares for a total consideration of CHF 400 million
Published: 2023-07-20 (Crawled : 07:00) - globenewswire.com
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 1.2%
H: 0.7%
C: 0.27%
license asia total
Sosei Heptares - Investor and Press Conference on Today’s Announcement Regarding the Acquisition and License Transaction with Idorsia
Published: 2023-07-20 (Crawled : 07:00) - globenewswire.com
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 1.2%
H: 0.7%
C: 0.27%
announcement conference license acquisition
FDA Issues Complete Response Letter (CRL) for Aflibercept 8 mg Biologics License Application Solely Due to an Ongoing Review of Inspection Findings at a Third-party Filler
Published: 2023-06-27 (Crawled : 18:00) - globenewswire.com
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 0.75%
H: 0.0%
C: 0.0%
REGN | $901.27 0.8% 0.78% 470K
|
Health Technology
|
| O: -1.1%
H: 0.26%
C: -1.16%
fda license review ongoing application response
Maze Therapeutics Announces Exclusive Worldwide License Agreement with Sanofi for MZE001, an Oral Substrate Reduction Therapy for the Treatment of Pompe Disease
Published: 2023-05-01 (Crawled : 12:00) - biospace.com/
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: 4.08%
H: 0.0%
C: 0.0%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -1.21%
H: 0.0%
C: 0.0%
mze001 disease license treatment therapeutics agreement therapy sanofi
Innate Pharma Announces Exclusive License of Antibodies to Takeda for Celiac Disease Research Program
Published: 2023-04-03 (Crawled : 07:00) - biospace.com/
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -0.05%
H: 0.0%
C: 0.0%
IPHA | $2.35 -9.27% -10.21% 16K
|
Health Technology
|
| O: 14.39%
H: 3.99%
C: -3.37%
pharma disease license research program
OPKO Health’s ModeX Therapeutics Enters into Exclusive Worldwide License and Collaboration Agreement with Merck to Develop Epstein-Barr Virus Vaccine Candidate
Published: 2023-03-08 (Crawled : 13:00) - globenewswire.com
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -0.93%
H: 0.0%
C: 0.0%
OPK | $1.255 3.72% 3.59% 4.7M
|
Health Technology
|
| O: 20.75%
H: 3.13%
C: -11.72%
candidate collaboration vaccine license virus therapeutics agreement
LifeArc co-founded company RQ Bio signs licensing agreement with AstraZeneca worth up to $157m plus royalties for monoclonal antibodies against SARS-CoV-2
Published: 2022-05-17 (Crawled : 07:00) - prnewswire.com
AZNCF | $135.305 -4.19% 1.1K
|
Health Technology
|
| O: 4.22%
H: 0.0%
C: -2.05%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 1.5%
H: 0.64%
C: 0.19%
AZN | $68.53 0.39% 0.39% 3.7M
|
Health Technology
|
| O: 3.17%
H: 0.0%
C: 0.0%
royalties sars-cov-2 license antibody
Rallybio Announces In-Licensing of Potential First-In-Class Preclinical Antibody Candidate from Sanofi
Published: 2022-05-10 (Crawled : 12:00) - biospace.com/
RLYB | News | $1.74 -3.33% -3.45% 520K
|
|
| O: -7.81%
H: 9.95%
C: 5.32%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 1.06%
H: 0.0%
C: 0.0%
preclinical antibody potential sanofi license pre-clinical
Terran Biosciences announces licensing deal with Sanofi for two late-stage CNS pipeline assets
Published: 2022-04-21 (Crawled : 13:00) - prnewswire.com
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: 0.07%
H: 0.08%
C: -1.12%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 2.02%
H: 0.0%
C: 0.0%
deal sanofi license
U.S. FDA Extends Review of Biologics License Application for REGEN-COV® (casirivimab and imdevimab) for Treatment and Prophylaxis of COVID-19
Published: 2022-04-14 (Crawled : 12:00) - biospace.com/
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: 3.34%
H: 0.0%
C: 0.0%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -1.56%
H: 0.0%
C: 0.0%
REGN | $901.27 0.8% 0.78% 470K
|
Health Technology
|
| O: 0.05%
H: 0.92%
C: 0.11%
covid-19 cov treatment fda application license review
ABL Bio Enters Global Collaboration and License Agreement with SANOFI to Advance ABL301 for the Treatment of Parkinson's Disease
Published: 2022-01-11 (Crawled : 01:00) - prnewswire.com
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: 2.11%
H: 2.91%
C: 2.91%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 0.9%
H: 0.0%
C: 0.0%
treatment license disease
Ligand and GSK Expand Global Collaboration and License Agreement
Published: 2021-12-21 (Crawled : 22:00) - biospace.com/
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 0.76%
H: 0.67%
C: 0.45%
LGND | News | $78.93 -1.24% -1.25% 180K
|
Health Technology
|
| O: -0.12%
H: 0.06%
C: -1.31%
license collaboration
Baidu Enters Into License Agreement With Sanofi to Enable Next-Generation mRNA Therapeutics and Vaccines
Published: 2021-11-22 (Crawled : 13:30) - prnewswire.com
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: -0.92%
H: 0.0%
C: -0.23%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -0.89%
H: 0.0%
C: 0.0%
BIDU | News | $94.43 -1.76% -1.79% 2.8M
|
Technology Services
|
| O: -1.31%
H: 0.0%
C: 0.0%
vaccine license therapeutics
2021 Worldwide Pharma, Biotech & Diagnostics Industry Report - Leading Licensing Deals by Value Since 2015
Published: 2021-11-10 (Crawled : 12:15) - prnewswire.com
SNYNF | News | $92.116 -2.18% 2.3K
|
Health Technology
|
| O: -0.54%
H: 0.0%
C: -0.01%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: 0.66%
H: 0.25%
C: -0.89%
biotech iot diagnostics license diagnostic pharma
Pfizer and BioNTech Initiate Rolling Submission of Supplemental Biologics License Application to U.S. FDA for Booster Dose of COMIRNATY® in Individuals 16 and Older
Published: 2021-08-25 (Crawled : 17:00) - globenewswire.com
PFE A | $25.42 -1.05% -0.04% 44M
|
Health Technology
|
| O: -0.7%
H: 0.5%
C: -1.1%
SNY | News | $46.125 0.71% 0.7% 3.7M
|
Health Technology
|
| O: -0.71%
H: 0.37%
C: 0.08%
BNTX | $86.42 0.09% 0.09% 1.2M
|
Health Technology
|
| O: -2.02%
H: 4.37%
C: 4.23%
fda license submission comirnaty® order
Gainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Your saved searches
Save your searches and get alerts when important news are released.